SCHEMBL9517233

SCHEMBL9517233

Cc1ccccc1C(=O)OCc1ccc(C(=O)NS(=O)(=O)CC(O)c2cccc(F)c2)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTT P42858 1/20 0.37
SCD O00767 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 2/20 0.35
GAA P10253 1/20 0.35
STAT1 P42224 1/20 0.35
RAB9A P51151 1/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
GRM5 P41594 1/20 0.35
LMNA P02545 3/20 0.34
TP53 P04637 3/20 0.34
MAPT P10636 2/20 0.34
P4HTM Q9NXG6 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
GABRA5 P31644 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9519649 0.88 GRM5 (0.38) GRM5P4HTMHDAC6GABRA5
SCHEMBL9517229 0.85 POLB (0.38) POLBSMN1; SMN2TDP1L3MBTL1KDM4E
SCHEMBL9516266 0.84 GRM5 (0.38) GRM5LMNAP4HTMHDAC6GABRA5
SCHEMBL9517030 0.81 SLC6A9 (0.39) POLBL3MBTL1RAB9AGRM5LMNA
SCHEMBL9517093 0.79 P4HTM (0.39) GAAADRB2ADRB1ADRB3MAPT
SCHEMBL9517994 0.78 P4HTM (0.49) POLBSMN1; SMN2L3MBTL1KDM4EGAA
SCHEMBL9515753 0.77 GABRA5 (0.50) POLBSMN1; SMN2TDP1L3MBTL1KDM4E
SCHEMBL9519641 0.77 SCD (0.41) SCDHDAC6
SCHEMBL9515611 0.77 EPHX2 (0.39) P4HTMHDAC6
SCHEMBL9515933 0.76 P4HTM (0.55) L3MBTL1KDM4EGAATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed